Possible association of NAT2 polymorphism with laryngeal cancer risk: An evidence-based meta-analysis

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 11, 2011, Pages 1661-1667

  Ying, Xin Jiang ^a   Dong, Pin ^a   Shen, Bin ^a   Wang, Jie ^a   Wang, Sang ^a   Wang, Guo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Laryngeal carcinoma; Meta analysis; NAT2; Polymorphism; Risk; Susceptibility

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

ACETYLATION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; EVIDENCE BASED PRACTICE; HUMAN; LARYNX CANCER; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ARYLAMINE N-ACETYLTRANSFERASE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LARYNGEAL NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 80054730799     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1045-6     Document Type: Article

References (32)

1. JAG Agundez 2008 Polymorphisms of human N-acetyltransferases and cancer risk Curr Drug Metab 9 6 520 531 18680472 10.2174/138920008784892083 1:CAS:528:DC%2BD1cXpslOjsb0%3D (Pubitemid 352025183)
2. CB Ambrosone S Kropp J Yang S Yao PG Shields J Chang-Claude 2008 Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: Pooled analysis and meta-analysis Cancer Epidemiol Biomarkers Prev 17 1 15 26 10.1158/1055-9965.epi-07-0598 18187392 10.1158/1055-9965.EPI-07-0598 1:CAS:528:DC%2BD1cXmt12itQ%3D%3D (Pubitemid 351196269)
3. CB Begg M Mazumdar 1994 Operating characteristics of a bank correlation test for publication bias Biometrics 50 4 1088 1101 7786990 10.2307/2533446 1:STN:280:DyaK2Mzgs1GrtQ%3D%3D
4. DA Bennett NK Latham C Stretton CS Anderson 2004 Capture-recapture is a potentially useful method for assessing publication bias J Clin Epidemiol 57 4 349 357 10.1016/j.jclinepi.2003.09.015 15135835 10.1016/j.jclinepi.2003.09.015 (Pubitemid 38609273)
5. M Blum DM Grant W McBride M Heim UA Meyer 1990 Human arylamine N-acetyltransferase genes-isolation, chromosomal localization, and functional expression DNA Cell Biol 9 3 193 203 2340091 10.1089/dna.1990.9.193 1:CAS:528:DyaK3cXls1Kns7w%3D
6. S Boccia G Cadoni FA Sayed-Tabatabaei M Volante D Arzani A De Lauretis C Cattel G Almadori CM Van Duijn G Paludetti G Ricciardi 2008 CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer J Cancer Res Clin Oncol 134 93 100 10.1007/s00432-007-0254-5 17611777 10.1007/s00432-007-0254-5 1:CAS:528:DC%2BD2sXht1KrurrL (Pubitemid 350060689)
7. Borlak J, Reamon-Buettner SM (2006) N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients. BMC Med Genet 7. doi: 10.1186/1471-2350-7-58 (Pubitemid 44203875)
8. N Brockton J Little L Sharp SC Cotton 2000 N-Acetyltransferase polymorphisms and colorectal cancer: A HuGE review Am J Epidemiol 151 9 846 861 10791558 1:STN:280:DC%2BD3c3ltVWqtQ%3D%3D (Pubitemid 30461126)
9. NJ Butcher S Boukouvala E Sim RF Minchin 2002 Pharmacogenetics of the arylamine N-acetyltransferases Pharmacogenomics J 2 1 30 42 11990379 10.1038/sj.tpj.6500053 1:CAS:528:DC%2BD38Xitl2ju7g%3D (Pubitemid 34982201)
10. M Chatzimichalis J Xenellis A Tzagaroulakis P Sarof K Banis M Gazouli A Bibas 2010 GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population J Laryngol Otol 124 3 318 323 10.1017/s002221510999154x 19922706 10.1017/S002221510999154X 1:STN:280:DC%2BC3c7gs1OltA%3D%3D
11. K Chen Q-T Jiang H-Q He 2005 Relationship between metabolic enzyme polymorphism and colorectal cancer World J Gastroenterol 11 3 331 335 15637738 1:CAS:528:DC%2BD2MXhs1ejsr4%3D (Pubitemid 40125233)
12. M Drozdz T Gierek A Jendryczko J Pilch J Piekarska 1987 N-acetyltransferase phenotype of patients with cancer of the larynx Neoplasma 34 4 481 484 3658048 1:STN:280:DyaL1c%2FhsVegtQ%3D%3D (Pubitemid 17140577)
13. M Egger GD Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test Br Med J 315 7109 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D (Pubitemid 27387172)
14. SA Frank 2004 Genetic predisposition to cancer-Insights from population genetics Nat Rev Genet 5 10 764 772 10.1038/nrg1450 15510167 10.1038/nrg1450 1:CAS:528:DC%2BD2cXot1Kju78%3D (Pubitemid 39336360)
15. M Gajecka M Rydzanicz R Jaskula-Sztul M Kujawski W Szyfter K Szyfter 2005 CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma Mutat Res Fundam Mol Mechan Mutagen 574 1-2 112 123 10.1016/j.mrfmmm.2005.01.027 10.1016/j.mrfmmm.2005.01.027 1:CAS:528: DC%2BD2MXks1eit7Y%3D (Pubitemid 40725973)
16. M Garcia-Closas N Malats D Silverman M Dosemeci M Kogevinas DW Hein A Tardon C Serra A Carrato R Garcia-Closas J Lloreta G Castano-Vinyals M Yeager R Welch S Chanock N Chatterjee S Wacholder C Samanic M Tora F Fernandez FX Real N Rothman 2005 NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses Lancet 366 9486 649 659 16112301 10.1016/S0140-6736(05)67137-1 1:CAS:528: DC%2BD2MXosVajsb0%3D (Pubitemid 41176017)
17. M Hashibe P Boffetta D Zaridze O Shangina N Szeszenia-Dabrowska D Mates E Fabianova P Rudnai P Brennan 2007 Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in central europe Am J Epidemiol 165 7 814 820 10.1093/aje/kwk066 17244634 10.1093/aje/kwk066 (Pubitemid 46434604)
18. DW Hein MA Doll AJ Fretland MA Leff SJ Webb GH Xiao US Devanoboyina NA Nangju Y Feng 2000 Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol Biomarkers Prev 9 1 29 42 10667461 1:CAS:528:DC%2BD3cXptVOmtA%3D%3D (Pubitemid 30062907)
19. S Henning I Cascorbi B Munchow V Jahnke I Roots 1999 Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk Pharmacogenetics 9 1 103 111 10208649 10.1097/00008571-199902000-00014 1:CAS:528:DyaK1MXjtlyqsb4%3D (Pubitemid 29176729)
20. JPT Higgins SG Thompson JJ Deeks DG Altman 2003 Measuring inconsistency in meta-analyses Br Med J 327 7414 557 560 10.1136/bmj.327.7414.557 (Pubitemid 37088507)
21. LE Johns RS Houlston 2000 N-acetyl transferase-2 and bladder cancer risk: a meta-analysis Environ Mol Mutagen 36 3 221 227 11044903 10.1002/1098- 2280(2000)36:3<221::AID-EM5>3.0.CO;2-Q 1:CAS:528:DC%2BD3cXnvVGgsbo%3D
22. N Jourenkova-Mironova H Wikman C Bouchardy K Mitrunen P Dayer S Benhamou A Hirvonen 1999 Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers Pharmacogenetics 9 4 533 537 10780274 1:CAS:528:DyaK1MXmtlGjs7c%3D (Pubitemid 29419573)
23. WJ Koskinen K Brondbo HM Dahlstrand T Luostarinen T Hakulinen I Leivo A Molijn WG Quint T Roysland E Munck-Wikland AA Makitie I Pyykko J Dillner A Vaheri LM Aaltonen 2007 Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study J Cancer Res Clin Oncol 133 9 673 678 10.1007/s00432-007-0219-8 17486368 10.1007/s00432-007-0219-8 (Pubitemid 47077059)
24. D Lei X Pan C Guo F Xu L Zhang D Liu X Luan 2002 Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma Zhonghua Zhongliu Zazhi 24 2 154 156 12015038 1:CAS:528: DC%2BD38Xkt1Ogu7c%3D
25. PM Marcus P Vineis N Rothman 2000 NAT2 slow acetylation and bladder cancer risk: a metaanalysis of 22 case-control studies conducted in the general population Pharmacogenetics 10 2 115 122 10761999 10.1097/00008571-200003000- 00003 1:CAS:528:DC%2BD3cXivVSjs7k%3D (Pubitemid 30193073)
26. S Morita M Yano T Tsujinaka Y Akiyama M Taniguchi K Kaneko H Miki T Fujii K Yoshino H Kusuoka M Monden 1999 Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma Int J Cancer 80 5 685 688 10048967 10.1002/(SICI)1097-0215(19990301)80:5<685::AID- IJC9>3.0.CO;2-W 1:CAS:528:DyaK1MXhtlSgsbg%3D (Pubitemid 29066278)
27. HM Ochs-Balcom G Wiesner RC Elston 2007 A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer Am J Epidemiol 166 3 246 254 10.1093/aje/kwm066 17535831 10.1093/aje/kwm066 (Pubitemid 47216806)
28. K Rouissi S Ouerhani R Marrakchi MR Ben Slama M Sfaxi M Ayed M Chebil AB El Gaaied 2009 Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population Cancer Genet Cytogenet 190 2 101 107 10.1016/j.cancergencyto.2009.01.007 19380028 10.1016/j.cancergencyto.2009.01.007 1:CAS:528:DC%2BD1MXkslGnurs%3D
29. M Rydzanicz M Wierzbicka M Gajecka W Szyfter K Szyfter 2005 The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck Cancer Lett 224 2 263 278 10.1016/j.canlet.2005.01.015 15914277 10.1016/j.canlet.2005.01.015 1:CAS:528:DC%2BD2MXks1GgtrY%3D (Pubitemid 40725847)
30. M Unal L Tamer Y Akbas YS Pata Y Vayisoglu U Degirmenci H Camdeviren 2005 Genetic polymorphism of N-acetyltransferase 2 in the susceptibility to laryngeal squamous cell carcinoma Head Neck J Sci Spec Head Neck 27 12 1056 1060 10.1002/hed.20284 (Pubitemid 41705583)
31. G Varzim E Monteiro R Silva C Pinheiro C Lopes 2002 Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility ORL J Oto-Rhino-Laryngol Relat Spec 64 3 206 212 10.1159/000058026 1:CAS:528:DC%2BD38XktVent7Y%3D (Pubitemid 34621727)
32. S Zienolddiny D Campa H Lind D Ryberg V Skaug LB Stangeland F Canzian A Haugen 2008 A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers Carcinogenesis 29 6 1164 1169 10.1093/carcin/bgn020 18258609 10.1093/carcin/bgn020 1:CAS:528:DC%2BD1cXot1Wjtr0%3D (Pubitemid 351958695)